Furthermore, we proceeded to investigate the therapeutic potential of anti-CD47 treatment in gastric cancer, revealing that the blockade of CD47 effectively impeded tumor growth by activating macrophage-mediated innate and adaptive immune responses. Here, CD47 is linked to gastric cancer.